MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

PT2399

CAS No. : 1672662-14-4

產品活性：PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC₅₀ of 6 nM. PT2399 displays potent antitumor activity in vivo.

研究領域：Metabolic Enzyme/Protease

作用靶點：HIF/HIF Prolyl-Hydroxylase

In Vitro: PT2399 (compound 10f) inhibits HIF-2α with an IC₅₀ of 6 nM.
PT2399 can bind directly to the HIF-2α PAS B domain, and cripple HIF-2α’s ability to bind to Aryl hydrocarbon receptor nuclear translocator (ARNT).
PT2399 (20 μM) causes off-target toxicity because it inhibits the proliferation of HIF-2α ?/? 786-O cells and other cancer cell lines with undetectable HIF-2α.
PT2399 (0.2–2 μM; 0-21 days) inhibits 786-O cells soft agar growth.
PT2399 represses various HIF target genes in 786-O VHL?/? ccRCC cells, does not suppress HIF-1α-specific targets such as BNIP3.

In Vivo: PT2399 inhibits tumor cell proliferation 3.5 fold in renal cell carcinoma (RCC) bearing mice.
PT2399 reduces tumor cell density and increases fibrosis in RCC bearing mice.
PT2399 (100 mg/kg; oral gavage; every 12 hours) is more active than SU 11248, and inhibits tumor growth in several SU 11248-resistant tumors in RCC bearing mice .
PT2399 directly inhibits HIF-2α causes tumor regression in preclinical models of primary and metastatic pVHL-defective ccRCC in an on-target fashion.

相關產品：Bioactive Compound Library Plus  |  Epigenetics Compound Library  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Oxygen Sensing Compound Library  |  Chemical Probe Library  |  Glutamine Metabolism Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Cancer Metabolism Compound Library  |  Angiogenesis-Related Compound Library  |  Transcription Factor-Targeted Library  |  Targeted Diversity Library  |  Cancer Stem Cells Compound Library  |  HIF-2α-IN-8  |  Glucosamine sulfate  |  HIF1-IN-3  |  Threo-Chloramphenicol-d₆  |  Amifostine trihydrate  |  Albendazole  |  AKBA  |  Deferoxamine  |  LW6  |  Dimethyl-bisphenol A  |  Ethyl 3,4-dihydroxybenzoate  |  Roxadustat  |  KG-548  |  Daprodustat  |  1,4-DPCA ethyl ester  |  AKB-6899  |  7-Hydroxyneolamellarin A  |  Glucosamine-¹³C₆,¹⁵N (hydrochloride)  |  BAY 87-2243  |  β,β-Dimethylacrylshikonin  |  PT-2385  |  Adaptaquin  |  (Rac)-Arnebin 1  |  Echinomycin  |  AFP464 free base  |  HIF-PHD-IN-1  |  1,4-DPCA

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物  |  寡核苷酸  |  抗體  |  點擊化學

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫，我們致力于為*科研客戶提供前沿的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業技術服務；
•   設有專業的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業團隊跟蹤最新的制藥及生命科學研究進展，為您提供*新的活性化合物；
•   與世界各大制藥公司及著名科研機構建立了長期的合作。